LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
BT-20 AZD 5438
3.33
uM
LJP6
1
J02
72
hr
1097 796 3610 0.2205 -0.1704
BT-20 AZD 5438
3.33
uM
LJP6
2
J02
72
hr
1097 774 3713 0.2084 -0.1800
BT-20 AZD 5438
3.33
uM
LJP6
3
J02
72
hr
1097 715 3696 0.1934 -0.2168
BT-20 AZD 5438
10
uM
LJP6
1
J01
72
hr
1097 525 3610 0.1454 -0.3488
BT-20 AZD 5438
10
uM
LJP6
2
J01
72
hr
1097 536 3713 0.1443 -0.3346
BT-20 AZD 5438
10
uM
LJP6
3
J01
72
hr
1097 559 3696 0.1512 -0.3195
BT-20 Pelitinib
0.04
uM
LJP5
1
I18
72
hr
1097 3281 3735 0.8784 0.8585
BT-20 Pelitinib
0.04
uM
LJP5
2
I18
72
hr
1097 3582 3877 0.9237 0.9147
BT-20 Pelitinib
0.04
uM
LJP5
3
I18
72
hr
1097 3581 3925 0.9123 0.9026
BT-20 Pelitinib
0.12
uM
LJP5
1
I17
72
hr
1097 2967 3735 0.7943 0.7557
BT-20 Pelitinib
0.12
uM
LJP5
2
I17
72
hr
1097 2836 3877 0.7314 0.6843
BT-20 Pelitinib
0.12
uM
LJP5
3
I17
72
hr
1097 3393 3925 0.8644 0.8476
BT-20 Pelitinib
0.37
uM
LJP5
1
I16
72
hr
1097 3078 3735 0.8241 0.7926
BT-20 Pelitinib
0.37
uM
LJP5
2
I16
72
hr
1097 3103 3877 0.8002 0.7696
BT-20 Pelitinib
0.37
uM
LJP5
3
I16
72
hr
1097 3018 3925 0.7688 0.7336
BT-20 Pelitinib
1.11
uM
LJP5
1
I15
72
hr
1097 2749 3735 0.7360 0.6815
BT-20 Pelitinib
1.11
uM
LJP5
2
I15
72
hr
1097 2633 3877 0.6790 0.6170
BT-20 Pelitinib
1.11
uM
LJP5
3
I15
72
hr
1097 2908 3925 0.7408 0.6989
BT-20 Pelitinib
3.33
uM
LJP5
1
I14
72
hr
1097 2312 3735 0.6190 0.5246
BT-20 Pelitinib
3.33
uM
LJP5
2
I14
72
hr
1097 2161 3877 0.5573 0.4508
BT-20 Pelitinib
3.33
uM
LJP5
3
I14
72
hr
1097 2295 3925 0.5847 0.4937
BT-20 Pelitinib
10
uM
LJP5
1
I13
72
hr
1097 714 3735 0.1912 -0.2158
BT-20 Pelitinib
10
uM
LJP5
2
I13
72
hr
1097 857 3877 0.2210 -0.1269
BT-20 Pelitinib
10
uM
LJP5
3
I13
72
hr
1097 852 3925 0.2171 -0.1285
BT-20 Luminespib
0.04
uM
LJP5
1
H18
72
hr
1097 1124 3735 0.3009 0.0137